Novel agents and strategies for overcoming EGFR TKIs resistance

Overview of attention for article published in Experimental Hematology & Oncology, January 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED…

Application WO-2015150826-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.